|
Useful links about clinical development
|
|
0
|
52
|
May 13, 2024
|
|
RSNN Annual Workshop 2025
|
|
0
|
39
|
May 15, 2025
|
|
CCMO symposium on academic drug development (NL)
|
|
0
|
75
|
January 24, 2025
|
|
Scientific advice for paediatric investigation plans (PIPs)
|
|
2
|
67
|
March 24, 2025
|
|
Platform Trials
|
|
0
|
25
|
March 14, 2025
|
|
Research Roadmap AmsterdamUMC useful for academic developers (not only in Amsterdam)
|
|
0
|
21
|
March 13, 2025
|
|
Overview of registries for rare diseases
|
|
2
|
21
|
January 23, 2025
|
|
How can I apply for a clinical study with product regulated under both CTR and IVDR (combined trial)?
|
|
1
|
19
|
January 23, 2025
|
|
How to include confidential information in CTIS?
|
|
1
|
21
|
January 20, 2025
|
|
CCMO webinar about the "Onderzoeksportaal" (NL)
|
|
0
|
22
|
January 8, 2025
|
|
How many participants are needed in my clinical First-In-Human (FIH) study to get a statistically sound answer?
|
|
2
|
45
|
January 17, 2025
|
|
Reimbursement of medication during clinical trial
|
|
1
|
27
|
January 16, 2025
|
|
JLABS - Road to first-in-human trials for small molecules (online and Leiden)
|
|
0
|
27
|
January 9, 2025
|
|
CCMO webinar about the new "onderzoeksportaal'
|
|
0
|
21
|
January 8, 2025
|
|
CCMO webinars over nieuw onderzoeksportaal
|
|
0
|
18
|
January 8, 2025
|
|
Guidance on Ethical, Legal, and Social Issues (ELSI)
|
|
1
|
30
|
December 12, 2024
|
|
Where can I ask for scientific advice for my clinical studies?
|
|
1
|
23
|
September 10, 2024
|
|
AI for drug combinations
|
|
0
|
21
|
August 21, 2024
|
|
Clinical trial for an extremely rare disease
|
|
1
|
25
|
August 21, 2024
|
|
Clinical trial application review
|
|
1
|
29
|
August 21, 2024
|
|
AI and prediction of side effects
|
|
0
|
22
|
July 31, 2024
|
|
Is it mandatory to include an IDMC/DSMB charter for the Dose Escalation Committee (DEC) for a phase I clinical study?
|
|
0
|
38
|
July 2, 2024
|
|
CTR - Is a legal representative required in the Netherlands
|
|
0
|
24
|
May 30, 2024
|
|
Retention period of data relating to traceability of ATMPs
|
|
0
|
21
|
May 30, 2024
|
|
Language on the label
|
|
0
|
20
|
May 30, 2024
|
|
Registration of unautorhised IMP in Extended EudraVigilance medicinal product dictionary (XEVMPD)
|
|
0
|
15
|
May 30, 2024
|
|
SUSAR reporting
|
|
0
|
21
|
May 13, 2024
|